Flixonase spray relieves GSK of £1.3m

GlaxoSmithKline is continuing the push behind its hayfever and allergy portfolio with a national press and poster campaign for Flixonase Allergy Nasal Spray.Breaking next week, the £1.35m package is the latest slice of the £4.65m that it has...